These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

731 related items for PubMed ID: 24243749

  • 1. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder WG, Hofmann W.
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [Abstract] [Full Text] [Related]

  • 2. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Kim WJ, Jeon YK, Kim BH, Kwak IS, Lee EK, Kim YK.
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [Abstract] [Full Text] [Related]

  • 3. Urinary NGAL, KIM-1 and L-FABP concentrations in antenatal hydronephrosis.
    Noyan A, Parmaksiz G, Dursun H, Ezer SS, Anarat R, Cengiz N.
    J Pediatr Urol; 2015 Oct; 11(5):249.e1-6. PubMed ID: 26096437
    [Abstract] [Full Text] [Related]

  • 4. Pre-transplant Evaluation of Donor Urinary Biomarkers can Predict Reduced Graft Function After Deceased Donor Kidney Transplantation.
    Koo TY, Jeong JC, Lee Y, Ko KP, Lee KB, Lee S, Park SJ, Park JB, Han M, Lim HJ, Ahn C, Yang J.
    Medicine (Baltimore); 2016 Mar; 95(11):e3076. PubMed ID: 26986138
    [Abstract] [Full Text] [Related]

  • 5. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
    Parmaksız G, Noyan A, Dursun H, İnce E, Anarat R, Cengiz N.
    Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD, Chronic Kidney Disease Biomarkers Consortium Investigators.
    Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
    [Abstract] [Full Text] [Related]

  • 9. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
    Pennemans V, Rigo JM, Faes C, Reynders C, Penders J, Swennen Q.
    Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
    [Abstract] [Full Text] [Related]

  • 10. Glomerular and tubular damage markers are elevated in patients with diabetes.
    Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT.
    Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
    [Abstract] [Full Text] [Related]

  • 11. Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography.
    Torregrosa I, Montoliu C, Urios A, Andrés-Costa MJ, Giménez-Garzó C, Juan I, Puchades MJ, Blasco ML, Carratalá A, Sanjuán R, Miguel A.
    Heart Vessels; 2015 Nov; 30(6):703-11. PubMed ID: 24989970
    [Abstract] [Full Text] [Related]

  • 12. NGAL (neutrophil gelatinase-associated lipocalin) and L-FABP after percutaneous coronary interventions due to unstable angina in patients with normal serum creatinine.
    Bachorzewska-Gajewska H, Poniatowski B, Dobrzycki S.
    Adv Med Sci; 2009 Nov; 54(2):221-4. PubMed ID: 19875355
    [Abstract] [Full Text] [Related]

  • 13. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U, Bachorzewska-Gajewska H, Malyszko J, Dobrzycki S.
    Adv Med Sci; 2013 Nov; 58(2):353-61. PubMed ID: 24384771
    [Abstract] [Full Text] [Related]

  • 14. Urinary L-FABP and its combination with urinary NGAL in early diagnosis of acute kidney injury after cardiac surgery in adult patients.
    Liu S, Che M, Xue S, Xie B, Zhu M, Lu R, Zhang W, Qian J, Yan Y.
    Biomarkers; 2013 Feb; 18(1):95-101. PubMed ID: 23167703
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
    Güneş A, Ece A, Aktar F, Tan İ, Söker M, Karabel D, Balık H, Uluca Ü, Şen V, Yolbaş İ.
    Med Sci Monit; 2015 Dec 24; 21():4023-9. PubMed ID: 26697893
    [Abstract] [Full Text] [Related]

  • 17. Effect of long-term storage of urine samples on measurement of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL).
    van de Vrie M, Deegens JK, van der Vlag J, Hilbrands LB.
    Am J Kidney Dis; 2014 Apr 24; 63(4):573-6. PubMed ID: 24268306
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil gelatinase-associated lipocalin and liver-type fatty acid-binding protein as biomarkers for acute kidney injury after organ transplantation.
    Iguchi N, Uchiyama A, Ueta K, Sawa Y, Fujino Y.
    J Anesth; 2015 Apr 24; 29(2):249-55. PubMed ID: 25205293
    [Abstract] [Full Text] [Related]

  • 19. Biomarkers of acute kidney injury in pediatric cardiac surgery.
    Peco-Antić A, Ivanišević I, Vulićević I, Kotur-Stevuljević J, Ilić S, Ivanišević J, Miljković M, Kocev N.
    Clin Biochem; 2013 Sep 24; 46(13-14):1244-51. PubMed ID: 23876402
    [Abstract] [Full Text] [Related]

  • 20. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS, Song SH, Kim IJ, Yang JY, Lee JG, Kwak IS, Kim YK.
    Diabetes Res Clin Pract; 2012 Aug 24; 97(2):251-7. PubMed ID: 22440044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.